Hilary Ann

A tribute to the fight against Breast Cancer
​
In tribute to our niece, Hilary Ann Rickher, we have created a very special wine. Cooper Ridge Vineyard's 'Hilary Ann' is a commemorative wine meant to increase the awareness of breast cancer and to help in raising funds for this disease. To date, we have donated over $5,000 to the Parr Cancer Fund and the Providence St. Vincent Cancer Research Fund!
​
We are very proud to continue to pledge a portion of the proceeds of each bottle sold
in honor of Hilary Ann Rickher to the Parr Cancer Fund and the Providence St. Vincent Cancer Research Fund.
​
​
​
​
​
​
The Woman
​
Vivacious. Dedicated. Loving. Athletic. Outgoing. Our niece, Hilary Ann, was everything to everyone.
​
The Cause
​
We lost our beloved niece in July of 2023; she was 43 years old. Her battle and loss was shattering for our family. After learning more about this devastating disease, Steve and Paula felt the Cooper Ridge community of wine lovers can make an impact in the fight against this disease by creating this Rioja-style red wine blend to remember her, and raise funds to help fight the disease.
​
The Wine
​
Like Hilary, the 2021 Hilary Ann red wine is a bold, full of character, yet a refined and balanced wine, a smooth and easy wine to enjoy with rich, deep color and a peppery finish. Made from our estate grown Tempranillo, Garnacha, Carignan, and Graciano fruit and aged 24 months in oak barrels.
​
The First Release
​
The 2021 'Hilary Ann' was an early release during our October 2024 fall wine club release party. Hilary’s parents, husband, and son joined us as we released this very special wine. The event was a weekend-long celebration of this remarkable young woman, wife, and mother.


'Hilary Ann' Red Blend
This multi-year Rioja-style red blend celebrates Hilary's strength and spirit. The wine is bold and complex, featuring 40% Tempranillo, 34% Carignan, and 26% Graciano - a peppery and slightly spicy blend that reflects her unmatched bravery and grace. Each sip carries her memory forward while supporting groundbreaking cancer research.
